Horsham, PA, United States of America

Robert E Boyd

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 117(Granted Patents)


Location History:

  • Cranbury, NJ (US) (2015)
  • Horsham, PA (US) (1997 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Robert E Boyd: A Pioneer in Biopharmaceutical Innovations

Introduction

Robert E Boyd, based in Horsham, Pennsylvania, is a prominent inventor with a remarkable portfolio of 32 patents to his name. His work primarily focuses on innovative treatments for various genetic and degenerative diseases, showcasing his dedication to enhancing healthcare through scientific advancements.

Latest Patents

Among his latest contributions to the field, Boyd has developed a groundbreaking method for treating Pompe disease utilizing 1-deoxynojirimycin derivatives. This method is designed to enhance the activity of mutant or wild-type α-glucosidase enzymes both in vitro and in vivo by using a specific pharmacological chaperone. Additionally, he has created a treatment protocol that includes administering a chaperone small molecule compound, a derivative of 1-deoxynojirimycin, which may significantly improve patient outcomes.

Another noteworthy patent focuses on preventing and treating degenerative disorders of the central nervous system and lysosomal storage disorders. His innovative approach provides novel compounds and methodologies aimed at tackling severe conditions such as Parkinson's disease, Alzheimer's disease, and Gaucher's disease.

Career Highlights

Robert E Boyd has had a distinguished career in the biopharmaceutical industry, having contributed his expertise to notable companies such as Amicus Therapeutics, Inc. and Ortho-McNeil Pharmaceutical Corporation. His tenure in these organizations has allowed him to be a part of pioneering research initiatives that push the boundaries of medical science.

Collaborations

Throughout his career, Boyd has collaborated with esteemed colleagues such as Gary Lee and Philip J Rybczynski. These partnerships have fostered an environment of innovative thinking and have been instrumental in driving forward the research and development efforts that result in his numerous patents.

Conclusion

Robert E Boyd stands out as a leading inventor who has significantly influenced the landscape of biopharmaceutical innovations. His extensive work on treatments for rare diseases and neurological disorders underscores the impact of dedicated research and collaboration in driving forward medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…